B‐Raf proto‐oncogene, Serine/Threonine kinase (termed BRAF) belongs to the RAF family of serine/threonine protein kinases, whose mutation accounts for 40‐60% of cutaneous melanomas.75 This evidence concerns the gene MARK2 and cutaneous melanoma.